Found: 38
Select item for more details and to access through your institution.
Pilot Study Shows Clinical Benefit with Nivolumab in Pediatric Patients with Hypermutant Cancers.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 12, p. 30
- By:
- Publication type:
- Article
Pharmacist-Driven Intervention Leads to Significant Increase in Biosimilar Adoption.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 12, p. 1
- By:
- Publication type:
- Article
Clinical NCCN Risk Classifcation Suboptimal for Some African-American Men with Prostate Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 26
- By:
- Publication type:
- Article
Survey Reveals Ongoing Misconceptions and Concerns Regarding Biosimilars.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 1
- By:
- Publication type:
- Article
Analysis of Healthcare Claims Shows Encouraging Trend in the Use of Trastuzumab Biosimilars.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 12
- By:
- Publication type:
- Article
The Benefits of Advance Care Planning During the COVID-19 Pandemic.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 11, p. 1
- By:
- Publication type:
- Article
HER2CLIMB Trial Results Confirm Survival Benefit with Tucatinib in HER2-Positive Breast Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 9, p. 1
- By:
- Publication type:
- Article
Aspacytarabine Safe and Effective in Patients with AML Unfit for Intensive Chemotherapy.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 10, p. 1
- By:
- Publication type:
- Article
A Successful Model for Integrating Biosimilars in a Community Oncology Practice.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 8, p. 32
- By:
- Publication type:
- Article
Targeted Therapies Improve Response Rates in Patients with Metastatic Urothelial Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 8, p. 26
- By:
- Publication type:
- Article
Daratumumab in Newly Diagnosed Multiple Myeloma: Weighing the Pros and Cons.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 8, p. 24
- By:
- Publication type:
- Article
Updates on the Treatment of HER2-Positive Metastatic Breast Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 8, p. 20
- By:
- Publication type:
- Article
Strategies for Dismantling Structural Racism in Oncology Pharmacy.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 8, p. 28
- By:
- Publication type:
- Article
Immunotherapy Continues to Transform the Treatment Landscape for Advanced NSCLC.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 7, p. 14
- By:
- Publication type:
- Article
Updates on the Use of Anticoagulants for Cancer-Associated Thromboembolism.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 7, p. 11
- By:
- Publication type:
- Article
New Opportunities in Clinical Trials and Drug Development After COVID-19.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 7, p. 17
- By:
- Publication type:
- Article
Best Practices for Optimizing Opioid Therapy in Patients with Cancer Pain.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 7, p. 1
- By:
- Publication type:
- Article
Impact of Health Disparities in Cancer Care.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 6, p. 26
- By:
- Publication type:
- Article
Axicabtagene Ciloleucel Demonstrates Durable Clinical Benefit in High-Risk Large B-Cell Lymphoma.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 1
- By:
- Publication type:
- Article
Glofitamab Step-Up Dosing Leads to High Response Rates in Relapsed or Refractory NHL.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 18
- By:
- Publication type:
- Article
Mosunetuzumab Offers Safe and Effective Treatment Option for Older Patients with DLBCL.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 3, p. 7
- By:
- Publication type:
- Article
Intervention Improves Quality of Life for Patients Experiencing Financial Toxicity.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 13
- By:
- Publication type:
- Article
Vodobatinib Effective in Patients with CML Regardless of Previous Ponatinib Therapy.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 2, p. 17
- By:
- Publication type:
- Article
The Impact of Social Determinants of Health on Cancer Care.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 1, p. 22
- By:
- Publication type:
- Article
Financial Hardship Affects Long-Term Outcomes for Patients with Cancer.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 1, p. 20
- By:
- Publication type:
- Article
Research Reveals Barriers to Clinical Trial Participation.
- Published in:
- Oncology Practice Management, 2021, v. 11, n. 1, p. 1
- By:
- Publication type:
- Article
Innovations in Quality Care: Lessons Learned.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 12, p. 35
- By:
- Publication type:
- Article
Multidisciplinary Cancer Care Should Start and End with the Patient.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 12, p. 29
- By:
- Publication type:
- Article
The Value of Some Cancer Drugs Changes Substantially After Their Approval.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 10, p. 54
- By:
- Publication type:
- Article
Anti-CD19 CAR T-Cells Lead to Durable Remissions in CLL and B-Cell Lymphomas.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 9, p. 20
- By:
- Publication type:
- Article
Intratumoral Administration of INT230-6 Improves Drug Diffusion and Uptake into Cancer Cells in Patients with Advanced Solid Tumors.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 9, p. 23
- By:
- Publication type:
- Article
Updated Results Indicate Long-Term Efficacy of Acalabrutinib in Treatment-Naïve Patients with CLL.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 9, p. 18
- By:
- Publication type:
- Article
Novel CAR T-Cell Therapy Shows Promise in Relapsed or Refractory Multiple Myeloma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 9, p. 16
- By:
- Publication type:
- Article
Standard of Care for Newly Diagnosed Multiple Myeloma Is Still Bortezomib, Lenalidomide, and Dexamethasone.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 9, p. 1
- By:
- Publication type:
- Article
Immunotherapy Doubles Progression-Free Survival in Subset of Patients with Advanced Colorectal Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 38
- By:
- Publication type:
- Article
Cemiplimab Cost-Effective for Advanced Cutaneous Squamous-Cell Carcinoma.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 33
- By:
- Publication type:
- Article
Clinical Decision Support Helps Compliance with Evidence-Based Pathways.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 31
- By:
- Publication type:
- Article
Germline Analysis Proves Valuable in Selecting Targetable Treatments for Patients with Advanced Cancer.
- Published in:
- Oncology Practice Management, 2020, v. 10, n. 8, p. 30
- By:
- Publication type:
- Article